The judgment distinguishes jurisdiction over a foreign company from jurisdiction over its offshore conduct, while leaving the Competition Act’s broader reach for another case.
Offshore companies are not beyond the Competition Commission’s reach, but a local connection alone will not be enough to bring them before South African competition authorities.
The Competition Commission failed to revive most claims against the banks, but the judgment clarifies the legal framework under which the remaining case will proceed.
The CMS cites statutory constraints, while the Portfolio Committee on Health calls for a clear roadmap to implement the Inquiry’s recommendations.
The agreement resolves a probe into alleged market-division in Toyota vehicle finance and removes restrictions that blocked WesBank from competing at dealerships.
Fedhealth’s acquisition of Medshield comes after Sanlam named Fedhealth its exclusive open medical scheme partner.
Experts warn that AI tools may quietly drive price-fixing and collusion, posing a new threat to competition law.
The Competition Tribunal has dismissed key objections from major pathology laboratories, moving the medical schemes closer to having their damages claim heard in the High Court.
The Universal Healthcare Access Coalition says the proposed tariff-setting measures for private healthcare side-step essential reforms.
But the government cannot afford to set up an independent supply-side regulator as recommended by the Health Market Inquiry.
The Board of Health Funders has ‘serious reservations’ about giving the Department of Health the power to manage the block exemption negotiation process.
It says the Competition Commission’s ruling hampers access to affordable private healthcare and contradicts recommendations from the Health Market Inquiry.
The Department of Health labels a report of a compromise on NHI as ‘ridiculous and unfounded’.
The regulations relate to commercial dealings among small businesses and agreements between suppliers, customers, and distributors.
The bank also says it closed the accounts of some 190 clients in 2023 following ‘reviews of client activity and related reputational risks’.
The combined business will have assets under administration of more than R230 billion.
S. Bacher & Company is a distributor and wholesaler of brands such as Tommy Hilfiger and Hugo Boss.
